Who are the innovators of future cell and gene therapies and personalized medicine?
Sponsored by
Sponsored by
Accelerating Science Forum: Round table debate on longevity and compliance in cell and gene therapies
Join our panel of multidisciplinary experts as they consider the longevity and
compliance of cell and gene therapies.
As part of a brand new Accelerating Science Feature,
SelectScience® will bring together experts and industry leaders in cell and gene therapy research,
manufacturing, and compliance to discuss the first-ever approval of a gene-editing-based therapy Casgevy.
Exploring the potential of other innovative cell and gene therapy types alongside this critical approval, key
topics such as monitoring long-term efficacy, identifying potential risks, improving manufacturing processes,
optimizing dosing regimens, and developing robust monitoring systems, will also be discussed. Whether you are
a researcher, healthcare professional, industry representative, or simply interested in the future of
medicine, this event will equip you with valuable knowledge and understanding of the challenges and potential
solutions related to the longevity and compliance of cell and gene therapies.
Gene editing therapies signal medical revolution
The approval of Casgevy and Lyfgenia signifies a remarkable leap forward in the
treatment of sickle cell disease, offering hope for patients seeking one-time, curative treatments. This
historic medical milestone signals the beginning of a new wave of personalized medicine and indicates a
transformative shift in the global approach to how we will treat genetic disorders and diseases in the years
ahead.
Cell and gene therapies pivotal for personalized medicine
The ability to precisely target diseases at the genetic and cellular levels,
tailor treatments to individual profiles, and potentially cure conditions marks a new era in healthcare. As
research and innovation continue to propel these therapies forward, the vision of truly personalized and
effective medical treatments is becoming a reality.
Explore the latest developments in cell and gene therapy with fellow scientists,
manufacturers, and regulatory experts.
Share your story, scientific knowledge, and accelerate science with SelectScience by becoming a
member.
"Results and analysis time highly improved" - Andreas Mitsch, Leibniz-Institut für Immuntherapie
"The xCELLigence RTCA SP has elevated our research" - Moira Geary, University of Pittsburgh
"The number of experiments you can run continuously with majority hands-off time is incredible." - Heather Lin, Emory University
We're here to provide an independent platform for you to share your experiences
and be heard by manufacturers. Your expert opinions on the scientific equipment and industry services used
in your lab are helping other scientists, laboratory professionals, and clinicians, find the best products
to accelerate scientific progress. We would like to thank all our valued reviewers for sharing their
expertise and supporting their peers in the process. We also invite you to leave your own reviews on the
products you use in your lab.
*Certain images and/or photos on this page are the copyrighted property of
123RF.com, its contributors or its licensed partners and are being used with permission under the relevant
license. These images and/or photos may not be copied or downloaded without permission from
123RF.com.
